BioDelivery Sciences ahead of schedule in developing neuropathy treatment
May 08, 2014 at 09:07 AM EDT
Raleigh drug developer BioDelivery Sciences International says it is ahead of schedule to test a proposed treatment for painful diabetic neuropathy (PDN)...